Search

Your search keyword '"McMahan, V"' showing total 4 results
Start Over Author "McMahan, V" Publisher escholarship, university of california
4 results on '"McMahan, V"'

1. Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis

Author

Glidden, David, Grant, Robert, Mulligan, Kathleen, Solomon, MM, Lama, JR, Glidden, DV, McMahan, V, Liu, AY, Vicente, J, Veloso, VG, Mayer, KH, and Chariyalertsak, S

Abstract

Objective: Tenofovir disoproxil fumarate (TDF) pre-exposure prophylaxis decreases sexual acquisition of HIV infection. We sought to evaluate the renal safety of TDF in HIV-uninfected persons. Design and methods: The Iniciativa Profilaxis Pre-Exposición (iP

Published
2014

2. Daily oral emtricitabine/tenofovir preexposure prophylaxis and herpes simplex virus type 2 among men who have sex with men

Author

Glidden, David, Grant, Robert, Marcus, JL, Glidden, DV, McMahan, V, Lama, JR, Mayer, KH, Liu, AY, Montoya-Herrera, O, Casapia, M, Hoagland, B, and Grant, RM

Abstract

Background: In addition to protecting against HIV acquisition, antiretroviral preexposure prophylaxis (PrEP) using topical 1% tenofovir gel reduced Herpes simplex virus type 2 (HSV-2) acquisition by 51% among women in the CAPRISA 004 study. We examined the

Published
2014

3. HIV-1 drug resistance in the iPrEx preexposure prophylaxis trial

Author

Glidden, David, Wong, Joseph, Grant, Robert, Liegler, T, Abdel-Mohsen, M, Bentley, LG, Atchison, R, Schmidt, T, Javier, J, Mehrotra, M, Eden, C, Glidden, DV, and McMahan, V

Abstract

© The Author 2014.Background: The iPrEx study demonstrated that combination oral emtricitabine and tenofovir disoproxil fumarate (FTC/TDF) as preexposure prophylaxis (PrEP) protects against HIV acquisition in men who have sex with men and transgender women

Published
2014

4. No Evidence of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxis

Author

Glidden, David, Grant, Robert, Marcus, JL, Glidden, DV, Mayer, KH, Liu, AY, Buchbinder, SP, Amico, KR, McMahan, V, Kallas, EG, Montoya-Herrera, O, and Pilotto, J

Abstract

Objective: Preexposure prophylaxis (PrEP) with emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) reduced HIV acquisition in the iPrEx trial among men who have sex with men and transgender women. Self-reported sexual risk behavior decreased overall, but

Published
2013

Catalog

Books, media, physical & digital resources
See catalog results